In one paragraphArticle in eLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
7 authors.
Shihching ChiuBeijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China.ORCID https://orcid.org/0009-0007-2572-6210 Qinchao ZhouBeijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China.
Chenglu XiaoSchool of Basic Medical Sciences, The Second Affiliated Hospital, Institute of Biomedical Innovation, The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, Jiangxi Medical College, Nanchang University, Nanchang, China.ORCID https://orcid.org/0000-0002-5880-7830 Linlu BaiBeijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China.
Xiaojun ZhuBeijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China.
Wanqiu DingBeijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China.
Jing-Wei XiongBeijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine, College of Future Technology, Peking University, Beijing, China.ORCID https://orcid.org/0000-0001-8438-4782 Funding
National Key Research and Development Program of China 2019YFA0801602National Key Research and Development Program of China 2023YFA1800600National Natural Science Foundation of China 31730061National Natural Science Foundation of China 32230032
6 · The paper itselfAbstract
The formation of blood-brain barrier and vascular integrity depends on the coordinated development of different cell types in the brain. Previous studies have shown that zebrafish
Indexed as
AngiogenesisBlood VesselsBrainNeovascularization, PhysiologicNeurogliaZebrafishZebrafish ProteinsAnimalsSignal TransductionTranscription FactorsTranscription FactorsZebrafish ProteinsbetaPixbrain blood vesselbrain hemorrhageconditional knockoutdevelopmental biologyzebrafish
Identifiers
PMID41543887
PMCPMC12810955
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390